Revolution Medicines (RVMD) Change in Cash (2019 - 2026)

Revolution Medicines has reported Change in Cash for 8 years, with the latest figure at $374.5 million in Q2 2026.

• On a quarterly basis, Change in Cash rose 441.95% year-over-year to $374.5 million in Q2 2026; TTM through Jun 2026 was $413.9 million, a 224.38% increase from a year earlier, with the FY2025 full-year figure at -$158.2 million, down 3.77% from the prior year.
• Change in Cash was $374.5 million for Q2 2026 at Revolution Medicines, up from $57.2 million in the prior quarter.
• The five-year high for Change in Cash was $374.5 million in Q2 2026, with the low at -$407.7 million in Q1 2024.
• Average Change in Cash over 5 years is $39.4 million, with a median of -$1.4 million recorded in 2022.
• The largest YoY upside for Change in Cash was 2554.39% in 2023 against a maximum downside of 667.35% in 2023.
• Over 5 years, Change in Cash stood at -$17.5 million in 2022, then surged by 2030.45% to $338.4 million in 2023, then climbed by 1.25% to $342.6 million in 2024, then tumbled by 51.46% to $166.3 million in 2025, then soared by 125.19% to $374.5 million in 2026.
• The last three Change in Cash figures came in at $374.5 million (Q2 2026), $57.2 million (Q1 2026), and $166.3 million (Q4 2025), per Business Quant data.